![Jean Hoffman-Censits Profile](https://pbs.twimg.com/profile_images/1111596684923097089/DwkjxKcZ_x96.jpg)
Jean Hoffman-Censits
@JCensits
Followers
545
Following
2K
Statuses
48
GU oncologist - bladder, UTUC, women’s bladder and small cell special interests. Mama Bear, lover of family, nature, travel. Foodie
Maryland, USA
Joined August 2015
Watch out for superstar mentee @elina_vlachou with @Ron_cology with one of her posters at GU ASCO!
0
5
23
@BladderCancerUS 2023 Baltimore BCAN walk raising awareness and supporting advocacy today and everyday @JHBladderCancer
0
2
14
A few human and furry members of the @JHBladderCancer team raising awareness for bladder cancer and UTUC this morning in Baltimore @MaxKates @djmcconkey @SHPatelMD1 @elina_vlachou
3
5
40
@elina_vlachou @hopkinskimmel @JHBladderCancer Folks watch out for this superstar!! So lucky to have you on the team!!
0
0
3
RT @TiansterZhang: Congratulations #VitalyMargulis, recipient of the #SwansonAward given to a notable uro-onc @MDAndersonNews alum — storie…
0
7
0
Thank you to @FaltasLab and @urotoday for highlighting our hypothesis generating work evaluating enfortumab related skin toxicity and response in urothelial CA
Cutaneous toxicity and response to enfortumab vedotin in #UrothelialCancer patients. #ExpertCommentary with @FaltasLab @WCMEnglanderIPM discussing work from Vlachou et al. in @EurUrolOpen > @elina_vlachou @JCensits @brady_urology @Andres_Matoso
1
6
18
@montypal @onepeloton @BradMcG04 @DanaFarber @DrChoueiri @PanMass @ASCO @BrainTumorDoc @ndenduluri1 @neerajaiims @PGrivasMDPhD @SuzanneColeMD @rodrocconi @GlopesMd @TiansterZhang @cityofhope @cityofhopeoc @KidneyCancer @kidneycan Welcome to the club- tons of GU representation! Sisterplatin107
2
0
6
Excited to share our hypothesis generating work on Enfortumab Vedotin and cutaneous toxicity @JHBladderCancer @djmcconkey @elina_vlachou @Andres_Matoso, and add to the mounting work in the field @LisaZabaMD @sandysrimd
0
6
24
RT @1Cause: Inspired educational programs for patients & families from Greenberg #Bladdercancer Institute @HopkinsMedicine @brady_urology @…
0
4
0
Thanks Dr San Chang @UroCancerMD and the team at UroToday for highlighting the care of patients with Upper Tract Urothelial Cancer and the importance of multidisciplinary care @SurenaMatinMD and Jonathan Coleman MD
A multidisciplinary approach to treating high-grade upper tract disease - A case-based approach. @SurenaMatinMD @MDAndersonNews, Jonathan Coleman, MD @MSKCancerCenter, and @JCensits @hopkinskimmel join @UroCancerMD in a case-based discussion on UroToday >
0
3
18
@CharuAggarwalMD @PennCancer @PennMedicine @onepeloton @PennMDForum @Ron_cology @lynn_schuchter @ASCO @PC3Innovation @PennPrecisMed @LovaSunMD @MMarmarelis @PennMedNews Congrats to David - amazing doc and scholar! AND peloton pal? Please pass along my congrats from sisterplatin107 😂
0
0
2
@shilpaonc @AlisonBirtle @PGrivasMDPhD @GreatDebatesCME So lovely to be a part - what a fantastic urothelial session- thanks to the organizers!
1
0
3
@ETUroOnc @EinsteinHealth @EinsteinUrology @JEFFUrology @KimmelCancerCtr Congratulations Ed! So thrilled for you and excited to hear about the great things to come for you at Einstein!
0
0
2
@MaxKates @SimaPorten @FaltasLab Yes wondering when the folks at O’Hare will start charging me room and board. hoping to see everyone soon
0
0
2
Now enrolling- a trial of chemo and immunotherapy for patients with small cell bladder cancer prior to surgery
Researchers @hopkinskimmel are conducting an immunotherapy+chemotherapy study for patients with localized invasive small cell #bladdercancer. For more information, including how to find out if you are eligible for the Small Cell Bladder Cancer Trial, visit
0
8
19
@allaf_mo @SHPatelMD1 @brady_urology Congratulations Sunil! We are so fortunate to have you!! Looking forward to watching your stellar career!
0
0
1
@drphil_urology @DrKarineTawagi @WesleyYipMD @ASCO Fantastic work! More stand alone UTUC trials with real data will help patients. UTUC trials are out there and on the horizon. Congrats to the team!
0
0
3